XOM
54
3
PEG
55
2
WY
36
5
GS
69
-3
BWA
61
-7
MAS
51
-11
UHS
60
-3
NTAP
72
10
ILMN
23
-5
ABBV
64
4
PYPL
31
2
SLB
46
2
AA
53
5
LRCX
55
-6
STI
15
-5
ZION
55
2
RCL
62
-3
FCX
67
14
UNM
70
2
TEL
83
-2
XOM
54
3
PEG
55
2
WY
36
5
GS
69
-3
BWA
61
-7
MAS
51
-11
UHS
60
-3
NTAP
72
10
ILMN
23
-5
ABBV
64
4
PYPL
31
2
SLB
46
2
AA
53
5
LRCX
55
-6
STI
15
-5
ZION
55
2
RCL
62
-3
FCX
67
14
UNM
70
2
TEL
83
-2
Financhill
Back

Journey Medical Vs. GT Biopharma Industry Stock Comparison

Sell
44

DERM
Journey Medical

Last Price:
3.45
Seasonality Move:
19.11%
Sell
16

GTBP
GT Biopharma

Last Price:
3.10
Seasonality Move:
4.06%
Sell
44
Journey Medical (DERM) is a Sell

Is Journey Medical a Buy, Sell or Hold?

  • The current Journey Medical [DERM] share price is $3.45. The Score for DERM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • DERM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
GT Biopharma (GTBP) is a Sell

Is GT Biopharma a Buy, Sell or Hold?

  • The current GT Biopharma [GTBP] share price is $3.12. The Score for GTBP is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • GTBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DERM Stock Price Chart

What is Journey Medical's stock price today?

  • The Journey Medical share price today is $3.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DERM is experiencing selling pressure, which indicates risk of future bearish movement.

GTBP Stock Price Chart

What is GT Biopharma's stock price today?

  • The GT Biopharma share price today is $3.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing selling pressure, which indicates risk of future bearish movement.

DERM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 45.05 Sell
Chaikin Money Flow: -67276 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.43 - 3.73) Sell
Bollinger Bands (100): (3.39 - 5.03) Sell

GTBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 40.36 Sell
Chaikin Money Flow: -6962 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.12 - 3.68) Sell
Bollinger Bands (100): (3.4 - 6.18) Sell

DERM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.56 Sell
20-day SMA: 3.54 Sell
50-day SMA: 3.64 Sell
200-day SMA: 3.86 Sell
8-day EMA: 3.55 Sell
20-day EMA: 3.59 Sell
50-day EMA: 3.74 Sell
200-day EMA: 3.74 Sell

GTBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.19 Sell
20-day SMA: 3.3 Sell
50-day SMA: 3.88 Sell
200-day SMA: 6.17 Sell
8-day EMA: 3.19 Sell
20-day EMA: 3.34 Sell
50-day EMA: 3.83 Sell
200-day EMA: 8.26 Sell

Journey Medical Earnings Growth & DERM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

GT Biopharma Earnings Growth & GTBP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $3.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.

Journey Medical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

GT Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):